查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1765260

全球结构性心臟疾病器材市场

Structural Heart Devices
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 194 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

预计到 2030 年全球结构性心臟疾病设备市场规模将达 280 亿美元

全球结构性心臟疾病器械市场规模预计在2024年为152亿美元，预计到2030年将达到280亿美元，2024年至2030年的复合年增长率为10.7%。心臟瓣膜器械是本报告分析的细分市场之一，预计其复合年增长率为11.3%，到分析期结束时规模将达到119亿美元。外科心臟瓣膜细分市场在分析期间的复合年增长率预计为10.7%。

美国市场规模估计为 42 亿美元，中国市场预期复合年增长率为 10.0%

美国结构性心臟疾病器械市场规模预计2024年达到42亿美元。作为世界第二大经济体，中国市场规模预计到2030年将达到43亿美元，在2024-2030年的分析期间内，复合年增长率为10.0%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间内，这两个市场的复合年增长率分别为9.5%和9.1%。在欧洲，预计德国市场的复合年增长率约为8.3%。

全球结构性心臟疾病设备市场—主要趋势与驱动因素摘要

结构性心臟疾病装置在现代医学中扮演什么角色？

结构性心臟疾病装置对于治疗主动脉瓣狭窄、二尖瓣瓣膜闭锁不全和心房中膈缺损症等结构性心臟疾病患者至关重要。这些装置包括心臟瓣膜、封堵器、环状成形术环和闭塞器，有助于修復或更换心臟受损或变形的部分。经导管主动脉瓣置换术(TAVR) 等微创技术的使用正在彻底改变心血管护理，它减少了开胸手术的需求，从而缩短了康復时间并缩短了住院时间。随着全球人口老化和心血管疾病的盛行率上升，结构性心臟疾病装置在满足手术併发症高风险患者的需求方面变得越来越重要。

哪些技术创新推动了结构性心臟疾病设备的发展？

技术创新是结构性心臟疾病器械市场的前沿，创新重点在于提高器械功效、降低手术风险和改善患者预后。其中最重要的发展之一是经导管技术，该技术无需开放性手术即可修復或更换心臟瓣膜。此外，3D超音波心动图和MRI等影像技术的改进使得手术计划和执行更加精确，从而减少併发症。此外，生物相容性材料的进步正在提高心臟瓣膜的耐用性和性能，而智慧技术的整合则实现了即时监测和术后护理。

哪个细分市场正在引领结构性心臟疾病设备的采用？

器械类型包括心臟瓣膜、封堵器、环状成形术环等。心臟瓣膜，尤其是经导管心臟瓣膜，因其广泛用于治疗心臟瓣膜疾病而占据市场主导地位。经导管主动脉瓣置换术(TAVR) 和经导管二尖瓣瓣膜修復(TMVR) 等手术正在推动对微创器械的需求。最终用户包括医院、门诊手术中心和专科诊所，其中医院因其拥有先进的医疗技术而成为最大的采用者。虽然北美和欧洲是结构性心臟疾病器材的最大市场，但亚太地区正因医疗基础设施的改善和人们对心血管治疗意识的提高而迅速崛起。

是什么推动了结构性心臟疾病设备市场的成长？

结构性心臟疾病器械市场的成长受到多种因素的推动，例如心血管疾病盛行率的上升、微创手术的普及以及经导管技术的进步。全球人口老化，尤其是在已开发地区，正在推动对心臟瓣膜置换术和其他结构性心臟介入治疗的需求。影像处理和生物相容性材料的技术创新正在提高这些器材的安全性和有效性，从而提高其采用率。此外，医疗保健支出的增加以及政府为改善先进心臟护理的可及性而采取的倡议，也推动了市场的成长，尤其是在新兴市场。

部分

产品（心臟瓣膜装置、外科心臟瓣膜、经​​导管心臟瓣膜、封堵器及输送系统、其他产品）

受访公司范例

  • Abbott Laboratories, Inc.
  • Boston Scientific Corporation
  • Braile Biomedica
  • CryoLife, Inc.
  • Edwards Lifesciences Corporation
  • Lepu Medical Technology（Beijing）Co., Ltd.
  • LivaNova PLC
  • Medtronic PLC
  • Micro Interventional Devices, Inc.
  • TTK Healthcare Ltd.

人工智慧集成

我们正在利用可操作的专家内容和人工智慧工具来改变市场和竞争情报。

Global 特定产业SLM 的典型规范，而是建立了一个从全球专家收集的内容库，其中包括视讯录影、部落格、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

全球产业分析师根据公司总部所在国家、製造地、进出口状况（成品和原始OEM）预测其竞争态势的变化。这种复杂且多面向的市场动态预计将以多种方式影响竞争对手，包括销货成本成本 (COGS) 上升、盈利下降、供应链重组以及其他微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

  • 市场概览
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 其他欧洲国家
  • 亚太地区
  • 其他地区

第四章 竞赛

简介目录
Product Code: MCP15047

Global Structural Heart Devices Market to Reach US$28.0 Billion by 2030

The global market for Structural Heart Devices estimated at US$15.2 Billion in the year 2024, is expected to reach US$28.0 Billion by 2030, growing at a CAGR of 10.7% over the analysis period 2024-2030. Heart Valve Devices, one of the segments analyzed in the report, is expected to record a 11.3% CAGR and reach US$11.9 Billion by the end of the analysis period. Growth in the Surgical Heart Valves segment is estimated at 10.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$4.2 Billion While China is Forecast to Grow at 10.0% CAGR

The Structural Heart Devices market in the U.S. is estimated at US$4.2 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$4.3 Billion by the year 2030 trailing a CAGR of 10.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 9.5% and 9.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 8.3% CAGR.

Global Structural Heart Devices Market - Key Trends and Drivers Summarized

What Role Do Structural Heart Devices Play in Modern Medicine?

Structural heart devices are critical in treating patients with structural heart diseases, including conditions such as aortic stenosis, mitral regurgitation, and atrial septal defects. These devices include heart valves, occluders, annuloplasty rings, and closure devices, which help repair or replace damaged or malformed parts of the heart. The use of minimally invasive technologies, such as transcatheter aortic valve replacement (TAVR), has revolutionized cardiovascular care by reducing the need for open-heart surgery, leading to faster recovery times and reduced hospital stays. As the global population ages and the prevalence of cardiovascular diseases rises, structural heart devices are becoming increasingly essential in addressing the needs of patients who are at higher risk of surgical complications.

What Technological Innovations Are Driving Growth in Structural Heart Devices?

Technological advancements are at the forefront of the structural heart devices market, with innovations focusing on improving device efficacy, reducing procedural risks, and enhancing patient outcomes. One of the most significant developments is in transcatheter technologies, which allow for the repair or replacement of heart valves without open surgery. Improvements in imaging technologies, such as 3D echocardiography and MRI, are also enabling more precise planning and execution of procedures, reducing complications. Additionally, advancements in biocompatible materials are enhancing the durability and performance of heart valves, while the integration of smart technologies is enabling real-time monitoring and post-procedure care.

Which Market Segments Are Leading the Adoption of Structural Heart Devices?

Device types include heart valves, closure devices, occluders, and annuloplasty rings, with heart valves, particularly transcatheter heart valves, dominating the market due to their widespread use in treating valvular heart diseases. Procedures such as transcatheter aortic valve replacement (TAVR) and transcatheter mitral valve repair (TMVR) are driving demand for minimally invasive devices. End-users include hospitals, ambulatory surgical centers, and specialty clinics, with hospitals being the largest adopters due to their access to advanced medical technologies. North America and Europe are the largest markets for structural heart devices, while Asia-Pacific is rapidly emerging due to improving healthcare infrastructure and increasing awareness of cardiovascular care.

What Is Driving the Growth of the Structural Heart Devices Market?

The growth in the structural heart devices market is driven by several factors, including the rising prevalence of cardiovascular diseases, increasing adoption of minimally invasive procedures, and advancements in transcatheter technologies. The aging global population, particularly in developed regions, is driving the demand for heart valve replacements and other structural heart interventions. Technological innovations in imaging and biocompatible materials are enhancing the safety and efficacy of these devices, leading to higher adoption rates. Additionally, increasing healthcare expenditure and government initiatives to improve access to advanced cardiac care are fueling market growth, particularly in emerging markets.

SCOPE OF STUDY:

The report analyzes the Structural Heart Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Heart Valve Devices, Surgical Heart Valves, Transcatheter Heart Valves, Occluders & Delivery Systems, Other Products)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 42 Featured) -

  • Abbott Laboratories, Inc.
  • Boston Scientific Corporation
  • Braile Biomedica
  • CryoLife, Inc.
  • Edwards Lifesciences Corporation
  • Lepu Medical Technology (Beijing) Co., Ltd.
  • LivaNova PLC
  • Medtronic PLC
  • Micro Interventional Devices, Inc.
  • TTK Healthcare Ltd.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Global Economic Update
    • Structural Heart Devices - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Growing Prevalence of Cardiovascular Diseases Drives Demand for Structural Heart Devices
    • Technological Advancements in Minimally Invasive Heart Valve Repair Propels Market Growth
    • Rising Adoption of Transcatheter Aortic Valve Replacement (TAVR) Expands Addressable Market Opportunity
    • Increasing Geriatric Population Strengthens Business Case for Structural Heart Devices
    • Surge in Heart Valve Replacement Procedures Accelerates Demand for Advanced Structural Heart Devices
    • Regulatory Approvals for Next-Generation Structural Heart Devices Propel Innovation in the Market
    • Growing Use of Structural Heart Devices in Treating Congenital Heart Defects Creates New Opportunities
    • Focus on Improving Patient Outcomes and Reducing Procedure Times Drives Adoption of Structural Heart Devices
    • Regulatory Changes and Increasing Healthcare Expenditure in Emerging Markets Fuel Market Growth
    • Surge in Demand for Non-Surgical and Minimally Invasive Treatment Options Spurs Adoption
    • Growing Awareness of Structural Heart Diseases and Diagnostic Tools Strengthens Market Penetration
    • Increasing Use of Structural Heart Devices in Hybrid Operating Rooms Expands Global Market Reach
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Structural Heart Devices Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Structural Heart Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for Structural Heart Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Heart Valve Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for Heart Valve Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Surgical Heart Valves by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for Surgical Heart Valves by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Transcatheter Heart Valves by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Occluders & Delivery Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for Occluders & Delivery Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 13: World 6-Year Perspective for Other Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Structural Heart Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 14: USA Recent Past, Current & Future Analysis for Structural Heart Devices by Product - Heart Valve Devices, Surgical Heart Valves, Transcatheter Heart Valves, Occluders & Delivery Systems and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 15: USA 6-Year Perspective for Structural Heart Devices by Product - Percentage Breakdown of Value Sales for Heart Valve Devices, Surgical Heart Valves, Transcatheter Heart Valves, Occluders & Delivery Systems and Other Products for the Years 2025 & 2030
  • CANADA
    • TABLE 16: Canada Recent Past, Current & Future Analysis for Structural Heart Devices by Product - Heart Valve Devices, Surgical Heart Valves, Transcatheter Heart Valves, Occluders & Delivery Systems and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 17: Canada 6-Year Perspective for Structural Heart Devices by Product - Percentage Breakdown of Value Sales for Heart Valve Devices, Surgical Heart Valves, Transcatheter Heart Valves, Occluders & Delivery Systems and Other Products for the Years 2025 & 2030
  • JAPAN
    • Structural Heart Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 18: Japan Recent Past, Current & Future Analysis for Structural Heart Devices by Product - Heart Valve Devices, Surgical Heart Valves, Transcatheter Heart Valves, Occluders & Delivery Systems and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 19: Japan 6-Year Perspective for Structural Heart Devices by Product - Percentage Breakdown of Value Sales for Heart Valve Devices, Surgical Heart Valves, Transcatheter Heart Valves, Occluders & Delivery Systems and Other Products for the Years 2025 & 2030
  • CHINA
    • Structural Heart Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 20: China Recent Past, Current & Future Analysis for Structural Heart Devices by Product - Heart Valve Devices, Surgical Heart Valves, Transcatheter Heart Valves, Occluders & Delivery Systems and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 21: China 6-Year Perspective for Structural Heart Devices by Product - Percentage Breakdown of Value Sales for Heart Valve Devices, Surgical Heart Valves, Transcatheter Heart Valves, Occluders & Delivery Systems and Other Products for the Years 2025 & 2030
  • EUROPE
    • Structural Heart Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 22: Europe Recent Past, Current & Future Analysis for Structural Heart Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 23: Europe 6-Year Perspective for Structural Heart Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 24: Europe Recent Past, Current & Future Analysis for Structural Heart Devices by Product - Heart Valve Devices, Surgical Heart Valves, Transcatheter Heart Valves, Occluders & Delivery Systems and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 25: Europe 6-Year Perspective for Structural Heart Devices by Product - Percentage Breakdown of Value Sales for Heart Valve Devices, Surgical Heart Valves, Transcatheter Heart Valves, Occluders & Delivery Systems and Other Products for the Years 2025 & 2030
  • FRANCE
    • Structural Heart Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 26: France Recent Past, Current & Future Analysis for Structural Heart Devices by Product - Heart Valve Devices, Surgical Heart Valves, Transcatheter Heart Valves, Occluders & Delivery Systems and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: France 6-Year Perspective for Structural Heart Devices by Product - Percentage Breakdown of Value Sales for Heart Valve Devices, Surgical Heart Valves, Transcatheter Heart Valves, Occluders & Delivery Systems and Other Products for the Years 2025 & 2030
  • GERMANY
    • Structural Heart Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 28: Germany Recent Past, Current & Future Analysis for Structural Heart Devices by Product - Heart Valve Devices, Surgical Heart Valves, Transcatheter Heart Valves, Occluders & Delivery Systems and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 29: Germany 6-Year Perspective for Structural Heart Devices by Product - Percentage Breakdown of Value Sales for Heart Valve Devices, Surgical Heart Valves, Transcatheter Heart Valves, Occluders & Delivery Systems and Other Products for the Years 2025 & 2030
  • ITALY
    • TABLE 30: Italy Recent Past, Current & Future Analysis for Structural Heart Devices by Product - Heart Valve Devices, Surgical Heart Valves, Transcatheter Heart Valves, Occluders & Delivery Systems and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 31: Italy 6-Year Perspective for Structural Heart Devices by Product - Percentage Breakdown of Value Sales for Heart Valve Devices, Surgical Heart Valves, Transcatheter Heart Valves, Occluders & Delivery Systems and Other Products for the Years 2025 & 2030
  • UNITED KINGDOM
    • Structural Heart Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 32: UK Recent Past, Current & Future Analysis for Structural Heart Devices by Product - Heart Valve Devices, Surgical Heart Valves, Transcatheter Heart Valves, Occluders & Delivery Systems and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: UK 6-Year Perspective for Structural Heart Devices by Product - Percentage Breakdown of Value Sales for Heart Valve Devices, Surgical Heart Valves, Transcatheter Heart Valves, Occluders & Delivery Systems and Other Products for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 34: Rest of Europe Recent Past, Current & Future Analysis for Structural Heart Devices by Product - Heart Valve Devices, Surgical Heart Valves, Transcatheter Heart Valves, Occluders & Delivery Systems and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 35: Rest of Europe 6-Year Perspective for Structural Heart Devices by Product - Percentage Breakdown of Value Sales for Heart Valve Devices, Surgical Heart Valves, Transcatheter Heart Valves, Occluders & Delivery Systems and Other Products for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Structural Heart Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 36: Asia-Pacific Recent Past, Current & Future Analysis for Structural Heart Devices by Product - Heart Valve Devices, Surgical Heart Valves, Transcatheter Heart Valves, Occluders & Delivery Systems and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 37: Asia-Pacific 6-Year Perspective for Structural Heart Devices by Product - Percentage Breakdown of Value Sales for Heart Valve Devices, Surgical Heart Valves, Transcatheter Heart Valves, Occluders & Delivery Systems and Other Products for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 38: Rest of World Recent Past, Current & Future Analysis for Structural Heart Devices by Product - Heart Valve Devices, Surgical Heart Valves, Transcatheter Heart Valves, Occluders & Delivery Systems and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Rest of World 6-Year Perspective for Structural Heart Devices by Product - Percentage Breakdown of Value Sales for Heart Valve Devices, Surgical Heart Valves, Transcatheter Heart Valves, Occluders & Delivery Systems and Other Products for the Years 2025 & 2030

IV. COMPETITION